Participants will dive into the current landscape of Triple-Negative Breast Cancer (TNBC), unraveling its complexities and shedding light on recent advancements. This session will review both early and late-stage treatments available and clinical trials for TNBC, and the pivotal role clinical trials play in shaping its future.
- Provider:Horizon CME, Inc.
- Activity Link: http://default/node/1477
- Start Date: 2024-04-19 05:00:00
- End Date: 2024-04-19 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest